| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,147 |
13,903 |
$541K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,731 |
7,178 |
$387K |
| Q3014 |
Telehealth originating site facility fee |
3,734 |
3,522 |
$78K |
| 99050 |
|
125 |
124 |
$6K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
56 |
12 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
62 |
58 |
$3K |
| 97169 |
|
49 |
48 |
$1K |
| 94726 |
|
125 |
121 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
19 |
19 |
$1K |
| 99215 |
Prolong outpt/office vis |
12 |
12 |
$980.88 |
| CP002 |
|
100 |
91 |
$975.10 |
| 94729 |
|
125 |
121 |
$844.87 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
89 |
67 |
$647.87 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
20 |
19 |
$445.37 |
| 94200 |
|
126 |
120 |
$428.93 |
| 92551 |
|
55 |
54 |
$239.60 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$177.80 |
| 99173 |
|
42 |
41 |
$89.76 |